|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/76 | |
| A61K 38/16 | |||
| A61K 35/768 | |||
| A61P 37/00 | |||
| A61K 39/12 |
| (11) | Patento numeris | 3008175 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14810447.4 |
| Europos patento paraiškos padavimo data | 2014-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/042444 |
| Data | 2014-06-15 |
| (87) | Numeris | WO 2014/201449 |
| Data | 2014-12-18 |
| (30) | Numeris | Data | Šalis |
| 201361835545 P | 2013-06-15 | US |
| (72) |
GRUBER, Harry, E., US
JOLLY, Douglas, J., US
LIN, Amy, H., US
|
| (73) |
Tocagen Inc.,
3030 Bunker Hill Street Suite 230, San Diego, CA 92109,
US
|
| (54) | IMMUNOSUPPRESSIVE VIRAL LIKE PARTICLES BASED ON GAMMARETROVIRUS |
| IMMUNOSUPPRESSIVE VIRAL LIKE PARTICLES BASED ON GAMMARETROVIRUS |